Survival benefits of fluoropyrimidine chemotherapy significantly outweighed the risks for cardiovascular events for patients with gastrointestinal cancers, according to results of an observational ...

Buffer strategies have experienced notable investor interest amid the 2025 bout of equity market volatility. Click to read.